Related Experiment Video
Updated: Jul 5, 2025

08:15
In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
Published on: December 9, 2022
1.8K
Effectiveness of a fourth mRNA dose among individuals with systemic autoimmune rheumatic diseases during the Omicron
Jessica Widdifield1, Jennifer J Y Lee2, Sasha Bernatsky3
1Holland Bone & Joint Program, Sunnybrook Research Institute, Toronto, ON M4N3M5, Canada; ICES, Toronto, ON, Canada; Institute of Health Policy, Management & Evaluation, Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
The Lancet. Rheumatology
|January 23, 2024
Abstract
No abstract available in PubMed .

